The MHRA are proposing to make Acnecide ‘Face’ products available from general sales outlets with more limited conditions of use than the current pharmacy products.
The products are Acnecide Face 5% w/w Gel and Acnecide Face Wash 5% w/w Gel. They are preparations (face gel and face wash) containing benzoyl peroxide intended for use on the face.
They are for the treatment of mild acne affecting the face in adults and adolescents aged 12 years and over.
The Commission on Human Medicines (CHM) has advised that Acnecide `Face’ products can be available as General Sale List (GSL) medicines.
Tell the MHRA your views using the form provided.
This deadline for comments is 5:00pm on 30 May 2019.